CORCEPT THERAPEUTICS INC Proceeds from Warrant Exercises
CORCEPT THERAPEUTICS INC (CORT) reported Proceeds from Warrant Exercises of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2018-02-28
- CORCEPT THERAPEUTICS INC proceeds from warrant exercises for fiscal 2017 was $0.00.
- CORCEPT THERAPEUTICS INC proceeds from warrant exercises for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- CORCEPT THERAPEUTICS INC proceeds from warrant exercises for fiscal 2015 was $17.09M.
- CORCEPT THERAPEUTICS INC proceeds from warrant exercises for fiscal 2014 was $0.00.
| Period end | Proceeds from Warrant Exercises 1 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-28 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 | |
| 2015-12-31 | $17.09M 10-K · filed 2018-02-28 | |
| 2015-03-31 | $17.10M 10-Q · filed 2016-05-04 | |
| 2014-12-31 | $0.00 10-K · filed 2017-03-06 | |
| 2012-12-31 | $470.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |